NCT07131826View on ClinicalTrials.gov

The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Viral ControlQuality of LifeCabotegravirRilpivirineAIDS
Interventions
OTHER

Observational study, non-interventional

Observational study, non-interventional

Trial Locations (1)

Unknown

NTUH, Taipei

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

lead

National Taiwan University Clinical Trial Center

OTHER